1) The arrangement to get the medication from Cuba came into being when the country was faced with a crisis of COVID 19 and the whole country was in a state of disaster. The AGSA's findings indicated that the Department of Defence (DOD) did not follow procurement processes. The DOD then recorded the Rm33.4 as irregular expenditure due to AGSA's findings. The return of the medication back to Cuba came out of a court order which the department had to comply with.
2) There was no misrepresentation of facts, on the matter, the Department had always recorded the irregularity in the financial records as irregular expenditure.
3) (a) The irregular expenditure will be treated as per the irregular expenditure framework prescribed by National Treasury.
(b) The process indicated above will determine the outcome.
(c) There are no further relevant details surrounding the matter.